Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016 - Yu, Jingjing; Zhou, Zhu; Tay-Sontheimer, Jessica; Levy, René H.; Ragueneau-Majlessi, Isabelle (Drug metabolism and disposition, 2018)
Keywords: Antiviral agents; ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism; CYP1A2 protein; CYP2D6 protein; Cytochrome P-450 Enzyme Inducers - pharmacokinetics; Cytochrome P-450 Enzyme System - metabolism; Cytochrome P450; Drug interaction; Drug interactions; Drug Interactions - physiology; Drugs; FDA approval; Food; Glycoproteins; Humans; Membrane Transport Proteins - metabolism; Oncology; P-Glycoprotein; Pharmaceutical Preparations - metabolism; Pharmacokinetics; Pharmacology; Substrates; United States; United States Food and Drug Administration; United States--US; BCRP; PGx; OCT; FDA; OAT; P-gp; FDC; NME; DDI; PBPK; CNS; MRP; NDA; OATP; NTR; AUC; UM; P450; PK; DME